Positive results from BioAge muscle atrophy trial

BioAge has announced positive data for BGE-105, a selective, potent, orally available small-molecule agonist of the apelin receptor APJ. 

Related Keywords

,William Evans ,Kristen Fortney ,Amgen ,Amgen Inc ,Bioage Labs Inc ,Duke University ,Bioage Labs ,